Sanara MedTech (SMTI) 10-K2022 FY Annual report

Filed: 20 Mar 23, 4:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: ahead, Alex, assay, attain, automated, AWG, bedside, BIASURGE, Biocidal, block, blocking, BlueIO, broaden, certainty, chose, clinician, competitor, contemplated, Cork, daily, Delaware, denial, dictate, dissolved, divestiture, dual, earnout, easier, evidencing, evolution, factual, finite, forma, fruition, Furneaux, Gitelman, hat, hereto, Holdback, Holdco, impossible, InfuSystem, instillation, inter, invoicing, JSM, Lastly, LFA, literature, MD, misappropriation, molded, nonaccredited, noncash, nonclinical, nonexclusive, noninfringing, nonmarketable, nonmisleading, nonmonetary, nonoperating, nonpatent, nonrenewal, NPWT, OfferingSM, opposition, optimizing, Orlando, orthobiologic, paired, partly, peripheral, postmarket, predominantly, pro, propriety, putty, qualitative, reacquire, ready, reclassed, redesign, reexamination, regenerative, registry, Relatedly, relinquished, rename, resumption, Ryan, scalable, screening, Seller, skincare, SmartTRAK, sophisticated, Spectral, sponsorship, strip, synergistically, territorial, thawing, unaudited, unenforceable, unexercised, unpredictable, upholding, USPTO, wash, William, withheld, withholding

Removed: ACell, annum, assure, bearing, borrowing, calculation, certification, characterized, commonly, compounded, consecutive, considerably, conversion, coordinated, disaggregation, division, duration, ending, execution, exposure, extending, geographical, implicit, incurrence, indeterminate, LLP, malonebailey, master, monthly, multitude, opportunity, outperform, overstated, package, promissory, prospective, reached, reconciliation, rental, sector, segregation, split, strong, structure, succeed, uncollectible, uninsured, unnecessary, unrelated, wealth

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated SMTI transcripts

SMTI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 21.1

Subsidiaries of Sanara MedTech Inc.

The following is a list of subsidiaries of Sanara MedTech Inc., a Texas corporation (the “Company”), as of December 31, 2022, the states in which they are organized and the Company’s percentage ownership of the issued and outstanding stock or other equity interests for each entity. The names of particular subsidiaries may be omitted if the unnamed subsidiaries, considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary as of the end of the year covered by the annual report on Form 10-K of which this Exhibit 21.1 forms a part. (See the definition of “significant subsidiary” in Rule 1-02(w) (17 CFR 210.1-02(w)) of Regulation S-X.)

Name of Subsidiary	State of Incorporation	Direct or Indirect Ownership Percentage
Cellerate, LLC	Texas		100	%
Wound Care Innovations, LLC	Nevada		100	%
Sanara Biologics, LLC	Texas		100	%
Rochal Technologies, LLC	Texas		100	%
WounDerm, LLC	Delaware		100	%⁽¹⁾
United Wound and Skin Solutions, LLC	Delaware		100	%
Precision Healing, LLC	Delaware		100	%⁽¹⁾
Scendia Biologics, LLC	Delaware		100	%

(1) Ownership of WounDerm, LLC and Precision Healing, LLC is held indirectly through United Wound and Skin Solutions, LLC, a wholly owned subsidiary of the Company.